Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival DOI
Ying Li,

Youliang Weng,

Zongwei Huang

et al.

JCO Precision Oncology, Journal Year: 2025, Volume and Issue: 9

Published: Jan. 1, 2025

PURPOSE Chronoradiobiology has emerged as a potential field of study with therapeutic implications for cancer treatment. We aimed to investigate the association between radiation chronotherapy and efficacy toxicity patients nasopharyngeal carcinoma (NPC). PATIENTS AND METHODS Patients nonmetastatic NPC treated intensity-modulated radiotherapy in Fujian Cancer Hospital January 2017 December 2019 were included. Propensity score matching (PSM) 1:1:1 was used account selection bias. Cox regression analysis performed explore impact timing on patient survival. Sensitivity implemented determine size directional stability. RESULTS One thousand forty met inclusion criteria 332 included PSM cohort. In unmatched cohort analysis, morning exhibited significantly superior overall survival (OS) outcome (hazard ratio [HR], 0.60 [95% CI, 0.40 0.91], adjusted log-rank P = .028) than afternoon one. After it observed that individuals undergoing group (HR, 5.88 2.55 13.58], .004) night 4.81 1.91 12.11], .018) displayed tendency toward shorter OS compared group. No significant differences acute treatment-related adverse effects among three groups. Morning demonstrated consistent robustness multivariable thereby establishing an higher OS. The directionality effect across sensitivity analysis. CONCLUSION These results underscore benefits scheduling management, although prospective studies are needed confirm these findings.

Language: Английский

Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy DOI Creative Commons
Chen Wang, Qun Zeng,

Zeynep Melis Gül

et al.

Cell, Journal Year: 2024, Volume and Issue: 187(11), P. 2690 - 2702.e17

Published: May 1, 2024

The quality and quantity of tumor-infiltrating lymphocytes, particularly CD8+ T cells, are important parameters for the control tumor growth response to immunotherapy. Here, we show in murine human cancers that these exhibit circadian oscillations, driven by both endogenous clock leukocytes rhythmic leukocyte infiltration, which depends on endothelial cells microenvironment. To harness rhythms therapeutically, demonstrate efficacy chimeric antigen receptor cell therapy immune checkpoint blockade can be improved adjusting time treatment during day. Furthermore, time-of-day-dependent signatures models predict overall survival patients with melanoma correlate anti-PD-1 therapy. Our data functional significance dynamics microenvironment suggest importance leveraging features improving future clinical trial design patient care.

Language: Английский

Citations

61

Spatiotemporal Metabolic Liver Zonation and Consequences on Pathophysiology DOI Creative Commons
Tomaž Martini, Félix Naef, Jan S. Tchorz

et al.

Annual Review of Pathology Mechanisms of Disease, Journal Year: 2023, Volume and Issue: 18(1), P. 439 - 466

Published: Jan. 24, 2023

Hepatocytes are the main workers in hepatic factory, managing metabolism of nutrients and xenobiotics, production recycling proteins, glucose lipid homeostasis. Division labor between hepatocytes is critical to coordinate complex complementary or opposing multistep processes, similar distributed tasks at an assembly line. This so-called metabolic zonation has both spatial temporal components. Spatial distribution function different lobular zones necessary perform sequential processes assign right environment. Moreover, control align required feeding fasting cycles. Disruption this spatiotemporal organization impairs key with local systemic consequences. Many diseases, such as nonalcoholic steatohepatitis diabetes, associated impaired liver zonation. Recent technological advances shed new light on gene expression networks controlling how their deregulation may be involved a large variety diseases. We summarize current knowledge about consequences pathobiology.

Language: Английский

Citations

51

Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis DOI Creative Commons
Thierry Landre, Abdoulaye Karaboué, Zachary S. Buchwald

et al.

ESMO Open, Journal Year: 2024, Volume and Issue: 9(2), P. 102220 - 102220

Published: Jan. 21, 2024

Background

Immune checkpoint inhibitors (ICIs) have become the standard of care for numerous malignancies. Emerging evidence suggests that time day (ToD) ICI administration could impact outcomes patients with cancer. The consistency ToD effects on efficacy awaits initial evaluation.

Materials and methods

This meta-analysis integrates progression-free survival (PFS) overall (OS) data from studies a defined ‘cut-off' ToD. Hazard ratios (HRs) [95% confidence interval (CI)] an earlier progression or death according to ‘early' ‘late' ICIs were collected each report pooled.

Results

Thirteen involved 1663 (Eastern Cooperative Oncology Group performance status 0-1, 83%; males/females, 67%/33%) non-small-cell lung cancer (47%), renal cell carcinoma (24%), melanoma (20%), urothelial (5%), esophageal (4%). Most received anti-programmed protein 1 death-ligand (98%), small proportion also anti-cytotoxic T-lymphocyte-associated 4 (anti-CTLA-4) (18%). cut-offs 13:00 14:00 (i.e. median infusion time), six studies, 16:00 16:30 reported threshold weaker vaccination responses) seven studies. Pooled analyses revealed early groups had longer OS (HR 0.50, 95% CI 0.42-0.58; P < 0.00001) PFS 0.51, 0.42-0.61; compared late groups.

Conclusions

Patients selected metastatic cancers seemed largely benefit infusions, which is consistent circadian mechanisms in immune-cell functions trafficking. Prospective randomized trials are needed establish recommendations optimal timing ICI-based therapies.

Language: Английский

Citations

25

Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade DOI
Bridget M. Fortin, Shannon M. Pfeiffer, Jacob Insua‐Rodríguez

et al.

Nature Immunology, Journal Year: 2024, Volume and Issue: 25(7), P. 1257 - 1269

Published: May 28, 2024

Language: Английский

Citations

22

Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis DOI
Yu Wang, Rajesh Narasimamurthy, Meng Qu

et al.

Nature Cancer, Journal Year: 2024, Volume and Issue: 5(4), P. 546 - 556

Published: April 23, 2024

Language: Английский

Citations

19

The circadian system, sleep, and the health/disease balance: a conceptual review DOI Creative Commons
Till Roenneberg, F. Foster, Elizabeth B. Klerman

et al.

Journal of Sleep Research, Journal Year: 2022, Volume and Issue: 31(4)

Published: June 7, 2022

Summary The field of “circadian medicine” is a recent addition to chronobiology and sleep research efforts. It represents logical step arising from the increasing insights into circadian system its interactions with life in urbanised societies; applying these health/disease balance at home medical practice (outpatient) clinic (inpatient). Despite fast expansion proliferating efforts, medicine lacks formal framework categorise many observations describing among system, sleep, balance. A good allows us then assign them one or more components hypothesised interactions. Such assignments can lead experiments that document causal (rather than correlational) relationships move discovering mechanisms. This review details such proposed for will hopefully trigger discussion our colleagues, so be improved expanded. As basis medicine, we define health” how it links general health. We put context literature examples six domains balance: fertility, cancer, immune mental health, cardiovascular, metabolism.

Language: Английский

Citations

53

Chronotherapy: Circadian Rhythms and Their Influence in Cancer Therapy DOI Open Access
Ana Amiama-Roig, Eva M. Verdugo‐Sivianes, Amancio Carnero

et al.

Cancers, Journal Year: 2022, Volume and Issue: 14(20), P. 5071 - 5071

Published: Oct. 17, 2022

Living organisms present rhythmic fluctuations every 24 h in their behavior and metabolism to anticipate changes the environment. These are controlled by a very complex molecular mechanism, circadian clock, that regulates expression of multiple genes ensure right functioning body. An individual’s system is altered during aging, this related numerous age-associated pathologies other alterations could contribute development cancer. Nowadays, there an increasing interest understanding how rhythms be used treatment Chronotherapy aims understand impact biological have on response therapy optimize its action, maximize health benefits minimize possible adverse effects. Clinical trials so far confirmed optimal timing with chemo or immunotherapies decrease drug toxicity increase efficacy. Instead, chronoradiotherapy seems treatment-related symptoms rather than tumor progression patient survival. In addition, potential therapeutic targets within clock also been identified. Therefore, results application chronotherapy cancer until now challenging, feasible, applied clinical practice improve without additional costs. However, different limitations variables such as age, sex, chronotypes, among others, should overcome before can really put into practice.

Language: Английский

Citations

48

Circadian Regulation of Drug Responses: Toward Sex-Specific and Personalized Chronotherapy DOI Creative Commons
Françis Lévi, Alper Okyar, Éva Hadadi

et al.

The Annual Review of Pharmacology and Toxicology, Journal Year: 2023, Volume and Issue: 64(1), P. 89 - 114

Published: Sept. 19, 2023

Today's challenge for precision medicine involves the integration of impact molecular clocks on drug pharmacokinetics, toxicity, and efficacy toward personalized chronotherapy. Meaningful improvements tolerability and/or medications through proper administration timing have been confirmed over past decade immunotherapy chemotherapy against cancer, as well commonly used pharmacological agents in cardiovascular, metabolic, inflammatory, neurological conditions. Experimental human studies recently revealed sexually dimorphic circadian responses. Dedicated randomized clinical trials should now aim to issue recommendations daily medical practice, integrating innovative technologies remote longitudinal monitoring metrics, statistical prediction clock function from single-timepoint biopsies, multiscale biorhythmic mathematical modelling. Importantly, chronofit patients with a robust function, who would benefit most chronotherapy, need be identified. Conversely, nonchronofit could emerging class chronobiotics targeting clock.

Language: Английский

Citations

32

Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer DOI Creative Commons
Adrien Rousseau, Marco Tagliamento, Édouard Auclin

et al.

European Journal of Cancer, Journal Year: 2023, Volume and Issue: 182, P. 107 - 114

Published: Jan. 13, 2023

Language: Английский

Citations

28

Chronotherapy in Glioblastoma: state of the art and future perspectives DOI Creative Commons
Marina Petković, Melad Henis,

Oliver Heese

et al.

EBioMedicine, Journal Year: 2023, Volume and Issue: 89, P. 104470 - 104470

Published: Feb. 15, 2023

Language: Английский

Citations

27